
Marrone Bio Innovations, Inc. – NASDAQ:MBII
Marrone Bio Innovations stock price today
Marrone Bio Innovations stock price monthly change
Marrone Bio Innovations stock price quarterly change
Marrone Bio Innovations stock price yearly change
Marrone Bio Innovations key metrics
Market Cap | N/A |
Enterprise value | 171.55M |
P/E | -6.82 |
EV/Sales | 3.86 |
EV/EBITDA | -11.83 |
Price/Sales | 3.27 |
Price/Book | 6.35 |
PEG ratio | N/A |
EPS | -0.11 |
Revenue | 44.36M |
EBITDA | -14.49M |
Income | -20.88M |
Revenue Q/Q | 0.53% |
Revenue Y/Y | 38.03% |
Profit margin | -47.08% |
Oper. margin | -43.72% |
Gross margin | 59.69% |
EBIT margin | -43.72% |
EBITDA margin | -32.67% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeMarrone Bio Innovations stock price history
Marrone Bio Innovations stock forecast
Marrone Bio Innovations financial statements
Jun 2021 | 12.59M | -3.03M | -24.09% |
---|---|---|---|
Sep 2021 | 9.85M | -4.94M | -50.17% |
Dec 2021 | 10.81M | -5.31M | -49.11% |
Mar 2022 | 11.09M | -7.59M | -68.45% |
2021-11-10 | -0.03 | -0.03 |
---|---|---|
2022-03-28 | -0.03 | -0.03 |
2022-05-11 | -0.02 | -0.04 |
Jun 2021 | 85618000 | 50.93M | 59.49% |
---|---|---|---|
Sep 2021 | 82138000 | 51.51M | 62.71% |
Dec 2021 | 87056000 | 57.40M | 65.94% |
Mar 2022 | 76214000 | 53.34M | 69.99% |
Jun 2021 | -1.24M | -425K | 213K |
---|---|---|---|
Sep 2021 | -308K | -361K | -1.75M |
Dec 2021 | -3.39M | -188K | 8.15M |
Mar 2022 | -8.39M | -198K | -1.66M |
Marrone Bio Innovations alternative data
Aug 2023 | 153 |
---|---|
Sep 2023 | 153 |
Oct 2023 | 153 |
Nov 2023 | 153 |
Dec 2023 | 153 |
Jan 2024 | 153 |
Feb 2024 | 153 |
Mar 2024 | 153 |
Apr 2024 | 153 |
May 2024 | 153 |
Jun 2024 | 153 |
Jul 2024 | 153 |
Marrone Bio Innovations other data
Period | Buy | Sel |
---|---|---|
Jul 2021 | 0 | 34865 |
Aug 2021 | 0 | 42368 |
Mar 2022 | 0 | 22728 |
May 2022 | 0 | 21009 |
Jun 2022 | 0 | 20492 |
Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
---|---|---|---|---|---|---|---|
Option | PITTS KEITH officer: SVP & Chief Sust. Offi.. | Restricted Stock Units | 102,950 | N/A | N/A | ||
Option | MOORE LINDA V officer: Chief Legal Officer | Restricted Stock Units | 316,153 | N/A | N/A | ||
Option | MAGO YOGESH director | Restricted Stock Units | 321,770 | N/A | N/A | ||
Option | MARRONE PAMELA G director | Restricted Stock Units | 195,007 | N/A | N/A | ||
Option | WOODS ROBERT A director | Restricted Stock Units | 455,027 | N/A | N/A | ||
Option | LEE LARA L director | Restricted Stock Units | 167,812 | N/A | N/A | ||
Option | VASAVADA AMIT officer: SVP & CTO | Restricted Stock Units | 129,184 | N/A | N/A | ||
Option | JOHNSON TIMOTHY B officer: VP (Field and Technical) | Restricted Stock Units | 102,167 | N/A | N/A | ||
Option | MCGOVERN KEITH director | Restricted Stock Units | 273,643 | N/A | N/A | ||
Option | WOCHOK ZACHARY S. director | Restricted Stock Units | 429,081 | N/A | N/A |
Patent |
---|
Application Filling date: 12 Mar 2020 Issue date: 11 Aug 2022 |
Grant Filling date: 30 Mar 2020 Issue date: 12 Jul 2022 |
Grant Filling date: 24 Jun 2019 Issue date: 12 Jul 2022 |
Application Filling date: 23 Nov 2021 Issue date: 16 Jun 2022 |
Application Filling date: 22 Nov 2021 Issue date: 17 Mar 2022 |
Application Filling date: 29 Oct 2019 Issue date: 17 Feb 2022 |
Application Use of Burkholderia Formulations, Compositions and Compounds to Modulate Crop Yield and/or Corn Rootworm Infestation Filling date: 12 Oct 2021 Issue date: 27 Jan 2022 |
Grant Utility: Herbicidal compound Filling date: 6 Sep 2018 Issue date: 28 Dec 2021 |
Application Filling date: 23 Aug 2021 Issue date: 23 Dec 2021 |
Application Filling date: 23 Aug 2021 Issue date: 16 Dec 2021 |
Quarter | Transcript |
---|---|
Q1 2022 11 May 2022 | Q1 2022 Earnings Call Transcript |
Q4 2021 28 Mar 2022 | Q4 2021 Earnings Call Transcript |
Q3 2021 10 Nov 2021 | Q3 2021 Earnings Call Transcript |
Q2 2021 16 Aug 2021 | Q2 2021 Earnings Call Transcript |
-
What's the price of Marrone Bio Innovations stock today?
One share of Marrone Bio Innovations stock can currently be purchased for approximately $0.8.
-
When is Marrone Bio Innovations's next earnings date?
Unfortunately, Marrone Bio Innovations's (MBII) next earnings date is currently unknown.
-
Does Marrone Bio Innovations pay dividends?
No, Marrone Bio Innovations does not pay dividends.
-
What is Marrone Bio Innovations's stock symbol?
Marrone Bio Innovations, Inc. is traded on the NASDAQ under the ticker symbol "MBII".
-
What is Marrone Bio Innovations's primary industry?
Company operates in the Basic Materials sector and Agricultural Inputs industry.
-
How do i buy shares of Marrone Bio Innovations?
Shares of Marrone Bio Innovations can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Marrone Bio Innovations's key executives?
Marrone Bio Innovations's management team includes the following people:
- Mr. Kevin R. Helash Chief Executive Officer & Director(age: 60, pay: $418,620)
- Dr. Pamela G. Marrone Ph.D. Founder, Advisor & Non-Employee Director(age: 68, pay: $408,630)
-
Is Marrone Bio Innovations founder-led company?
Yes, Marrone Bio Innovations is a company led by its founder Dr. Pamela G. Marrone Ph.D..
-
How many employees does Marrone Bio Innovations have?
As Jul 2024, Marrone Bio Innovations employs 153 workers.
-
When Marrone Bio Innovations went public?
Marrone Bio Innovations, Inc. is publicly traded company for more then 12 years since IPO on 2 Aug 2013.
-
What is Marrone Bio Innovations's official website?
The official website for Marrone Bio Innovations is marronebio.com.
-
Where are Marrone Bio Innovations's headquarters?
Marrone Bio Innovations is headquartered at 1540 Drew Ave, Davis, CALIFORNIA.
-
How can i contact Marrone Bio Innovations?
Marrone Bio Innovations's mailing address is 1540 Drew Ave, Davis, CALIFORNIA and company can be reached via phone at +1 530 750 2800.
Marrone Bio Innovations company profile:

Marrone Bio Innovations, Inc.
marronebio.comNASDAQ
153
Agricultural Inputs
Basic Materials
Marrone Bio Innovations, Inc. discovers, develops, and sells biological products for crop protection, crop health, and crop nutrition. Its products include Emergen, Foramin, Foramin ST, Optima, Takla, Pacesetter, Ympact, UBP, and UBP ST for increasing crop health, yield, and quality; Grandevo, a bioinsecticide that controls sucking and chewing insects through feeding; Haven, a plant health product to reduce sun stress and dehydration; Jet-Ag and Jet-Oxide peroxyacetic acid sanitizers that prevent, suppress, eliminate, and control algae, fungi, and bacterial diseases in agriculture and horticultural industries; and Majestene, a bionematicide to control soil-dwelling nematodes and certain soil borne insects. The company also offers Regalia and Stargus, which protects against fungal and bacterial diseases and enhances yields/quality; Venerate, a bioinsecticide that controls chewing and sucking insects and mites; and Zelto, a bionematicide that protects turf, including golf course fairways and greens, and promotes turf health by enhancing plant and root health. It provides its products directly through sales force, as well as through distributors and other commercial partners. The company formerly known as Marrone Organic Innovations, Inc. Marrone Bio Innovations, Inc. was incorporated in 2006 and is headquartered in Raleigh, North Carolina.
Davis, CALIFORNIA 27617
CIK: 0001441693
ISIN: US57165B1061
CUSIP: 57165B106